End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding
LUND (SWEDEN) – As we near the holidays and year end, I am energized by what Immunovia has accomplished in 2024 and the opportunities that lie ahead in 2025. In 2024 we rapidly delivered multiple key milestones to put Immunovia on a path to success As 2024 began, we had recently completed a significant transformation of the company. We were a much smaller, more agile team focused on the development of our next-generation test. This focus—and the talents of the Immunovia team—drove excellent progress in 2024. Key highlights: · We developed accurate and reliable lab